Filtros : "Indexado no Reference Update" "DOENÇAS CARDIOVASCULARES" "FCF" Removidos: "FBF003" "Chamone, Dalton de Alencar Fischer" "ENGLER, SILVYA STUCHI MARIA" "Financiado pela Emory University School of Medicine" Limpar

Filtros



Refine with date range


  • Source: Nephron Clinical Practice. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, HEMODIÁLISE, DOENÇAS CARDIOVASCULARES

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBO, Julie Calixto et al. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clinical Practice, v. 108, n. 4, p. c298-c304, 2008Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf. Acesso em: 11 out. 2024.
    • APA

      Lobo, J. C., Santos, F., Grosso, D. de M., Lima, F., Barreira, A. F., Mafra, D., & Abdalla, D. S. P. (2008). Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clinical Practice, 108( 4), c298-c304. Recuperado de http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
    • NLM

      Lobo JC, Santos F, Grosso D de M, Lima F, Barreira AF, Mafra D, Abdalla DSP. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis [Internet]. Nephron Clinical Practice. 2008 ; 108( 4): c298-c304.[citado 2024 out. 11 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
    • Vancouver

      Lobo JC, Santos F, Grosso D de M, Lima F, Barreira AF, Mafra D, Abdalla DSP. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis [Internet]. Nephron Clinical Practice. 2008 ; 108( 4): c298-c304.[citado 2024 out. 11 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
  • Source: Clinical Biochemistry. Unidade: FCF

    Subjects: DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE, INFARTO DO MIOCÁRDIO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, Jair A. et al. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clinical Biochemistry, v. 39, n. 7, p. 708-714, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2006.05.002. Acesso em: 11 out. 2024.
    • APA

      Oliveira, J. A., Sevanian, A., Rodrigues, R. J., Apolinário, E., & Abdalla, D. S. P. (2006). Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clinical Biochemistry, 39( 7), 708-714. doi:10.1016/j.clinbiochem.2006.05.002
    • NLM

      Oliveira JA, Sevanian A, Rodrigues RJ, Apolinário E, Abdalla DSP. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes [Internet]. Clinical Biochemistry. 2006 ; 39( 7): 708-714.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.05.002
    • Vancouver

      Oliveira JA, Sevanian A, Rodrigues RJ, Apolinário E, Abdalla DSP. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes [Internet]. Clinical Biochemistry. 2006 ; 39( 7): 708-714.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.05.002
  • Source: Journal of the American College of Cardiology. Unidades: FCF, FM

    Subjects: DOENÇAS CARDIOVASCULARES, LIPOPROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SPÓSITO, Andrei Carvalho et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, v. 43, n. 12, p. 2225-2232, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2003.11.065. Acesso em: 11 out. 2024.
    • APA

      Spósito, A. C., Lemos, P. A., Santos, R. D., Hueb, W., Vinagre, C. G. C. de M., Quintella, E., et al. (2004). Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, 43( 12), 2225-2232. doi:10.1016/j.jacc.2003.11.065
    • NLM

      Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
    • Vancouver

      Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
  • Source: Journal of Clinical Laboratory Analysis. Unidade: FCF

    Subjects: POLIMORFISMO, DOENÇAS CARDIOVASCULARES, HIPERTENSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SAKUMA, Tatsuya e HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Five polymorphisms in gene candidates for cardiovascular disease in afro-Brazilian individuals. Journal of Clinical Laboratory Analysis, v. 18, n. 6, p. 309-316, 2004Tradução . . Disponível em: https://doi.org/10.1002/jcla.20044. Acesso em: 11 out. 2024.
    • APA

      Sakuma, T., Hirata, R. D. C., & Hirata, M. H. (2004). Five polymorphisms in gene candidates for cardiovascular disease in afro-Brazilian individuals. Journal of Clinical Laboratory Analysis, 18( 6), 309-316. doi:10.1002/jcla.20044
    • NLM

      Sakuma T, Hirata RDC, Hirata MH. Five polymorphisms in gene candidates for cardiovascular disease in afro-Brazilian individuals [Internet]. Journal of Clinical Laboratory Analysis. 2004 ; 18( 6): 309-316.[citado 2024 out. 11 ] Available from: https://doi.org/10.1002/jcla.20044
    • Vancouver

      Sakuma T, Hirata RDC, Hirata MH. Five polymorphisms in gene candidates for cardiovascular disease in afro-Brazilian individuals [Internet]. Journal of Clinical Laboratory Analysis. 2004 ; 18( 6): 309-316.[citado 2024 out. 11 ] Available from: https://doi.org/10.1002/jcla.20044

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024